TWA
ATRA icon

TCI Wealth Advisors’s Atara Biotherapeutics ATRA Stock Holding History

TCI Wealth Advisors’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-34
Closed -$7K – 2248
2022
Q2 		$7K Buy
+34
New +$5.55K ﹤0.01% 1209
2022
Q1 		– Sell
-14
Closed -$6K – 2221
2021
Q4 		$6K Buy
14
+8
+133% +$3.37K ﹤0.01% 1496
2021
Q3 		$3K Hold
6
– – ﹤0.01% 1900
2021
Q2 		$2K Buy
6
+1
+20% +$357 ﹤0.01% 1949
2021
Q1 		$2K Buy
+5
New +$2.21K ﹤0.01% 1665
2020
Q4 		– Sell
-4
Closed -$1K – 1537
2020
Q3 		$1K Hold
4
– – ﹤0.01% 1267
2020
Q2 		$1K Hold
4
– – ﹤0.01% 1204
2020
Q1 		$1K Hold
4
– – ﹤0.01% 1183
2019
Q4 		$2K Hold
4
– – ﹤0.01% 1099
2019
Q3 		$1K Buy
+4
New +$1.49K ﹤0.01% 1225

Other funds holding ATRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return